Erratum: Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates (Biomacromolecules (2013) 14:3 (920-929) DOI: 10.1021/bm301999c);Drug-initiated ring-opening polymerization of O-carboxyanhydrides for the preparation of anticancer drug-poly(O-carboxyanhydride) nanoconjugates

Biomacromolecules

Volumn 14, Issue 3, 2013, Pages 920-929

  Yin, Qian ^a   Tong, Rong ^a,b   Xu, Yunxiang ^a   Baek, Kwanghyun ^a   Dobrucki, Lawrence W ^a   Fan, Timothy M ^c   Cheng, Jianjun ^a  

^a University of Illinois at Urbana Champaign   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; BIOMATERIALS; BODY FLUIDS; CONJUGATED POLYMERS; DRUG PRODUCTS; NANOCONJUGATES; PARTICLE SIZE; PARTICLE SIZE ANALYSIS; RING OPENING POLYMERIZATION; TARGETED DRUG DELIVERY;

CONTROLLED PARTICLE SIZES; CONTROLLED POLYMERIZATION; CONVENTIONAL POLYMERS; DRUG-LOADING EFFICIENCY; INTERCHAIN INTERACTIONS; PHYSICOCHEMICAL PROPERTY; SUSTAINED DRUG RELEASE; SYNTHETIC STRATEGIES;

CONTROLLED DRUG DELIVERY;

CAMPTOTHECIN; DOCETAXEL; DOXORUBICIN; HYDROXYL GROUP; NANOCONJUGATE; NANOPARTICLE; PACLITAXEL; PHENYL O CARBOXYANHYDRIDE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STABILITY; FEMALE; HUMAN; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

EID: 84874851241     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm500814f     Document Type: Erratum

References (42)

1. Langer, R. Nature 1998, 392, 5-10
2. Peer, D.; Karp, J. M.; Hong, S.; FaroKhzad, O. C.; Margalit, R.; Langer, R. Nat. Nanotechnol. 2007, 2, 751-760
3. Farokhzad, O. C.; Langer, R. Adv. Drug Delivery Rev. 2006, 58, 1456-1459
4. Wagner, V.; Dullaart, A.; Bock, A. K.; Zweck, A. Nat. Biotechnol. 2006, 24, 1211-1217
5. Duncan, R. Nat. Rev. Cancer 2006, 6, 688-701
6. Greco, F.; Vicent, M. J. Adv. Drug Delivery Rev. 2009, 61, 1203-1213
7. Duncan, R.; Ringsdorf, H.; Satchi-Fainaro, R. J. Drug Targets 2006, 14, 337-341
8. Duncan, R. Anti-Cancer Drugs 1992, 3, 175-210
9. Musumeci, T.; Ventura, C. A.; Giannone, I.; Ruozi, B.; Montenegro, L.; Pignatello, R.; Puglisi, G. Int. J. Pharm. 2006, 325, 172-179
10. Yu, Y.; Zou, J.; Yu, L.; Jo, W.; Li, Y. K.; Law, W. C.; Cheng, C. Macromolecules 2011, 44, 4793-4800
11. Lendlein, A.; Langer, R. Science 2002, 296, 1673-1676
12. Kim, B. Y. S.; Rutka, J. T.; Chan, W. C. W. N. Engl. J. Med. 2010, 363, 2434-2443
13. Farokhzad, O. C.; Cheng, J. J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6315-6320
14. Tong, R.; Cheng, J. J. Polym. Rev. 2007, 47, 345-381
15. Cheng, J.; Teply, B. A.; Sherifi, I.; Sung, J.; Luther, G.; Gu, F. X.; Levy-Nissenbaum, E.; Radovic-Moreno, A. F.; Langer, R.; Farokhzad, O. C. Biomaterials 2007, 28, 869-876
16. Tong, R.; Yala, L. D.; Fan, T. M.; Cheng, J. J. Biomaterials 2010, 31, 3043-3053
17. Tong, R.; Cheng, J. J. J. Am. Chem. Soc. 2009, 131, 4744-4754
18. Tong, R.; Cheng, J. J. Macromolecules 2012, 45, 2225-2232
19. Tong, R.; Cheng, J. J. Angew. Chem. Int. Ed. 2008, 47, 4830-4834
20. Miller, T.; Hill, A.; Uezguen, S.; Weigandt, M.; Goepferich, A. Biomacromolecules 2012, 13, 1707-1718
21. Seyednejad, H.; Ghassemi, A. H.; van Nostrum, C. F.; Vermonden, T.; Hennink, W. E. J. Controlled Release 2011, 152, 168-176
22. Simmons, T. L.; Baker, G. L. Biomacromolecules 2001, 2, 658-663
23. du Boullay, O. T.; Bonduelle, C.; Martin-Vaca, B.; Bourissou, D. Chem. Commun. 2008, 1786-1788
24. Pounder, R. J.; Fox, D. J.; Barker, I. A.; Bennison, M. J.; Dove, A. P. Polym. Chem. 2011, 2, 2204-2212
25. Lu, Y. B.; Yin, L. C.; Zhang, Y. F.; Zhang, Z. H.; Xu, Y. X.; Tong, R.; Cheng, J. J. ACS Macro Lett. 2012, 1, 441-444
26. Chamberlain, B. M.; Cheng, M.; Moore, D. R.; Ovitt, T. M.; Lobkovsky, E. B.; Coates, G. W. J. Am. Chem. Soc. 2001, 123, 3229-3238
27. Xiao, Y. L.; Hong, H.; Matson, V. Z.; Javadi, A.; Xu, W.; Yang, Y. A.; Zhang, Y.; Engle, J. W.; Nickles, R. J.; Cai, W. B.; Steeber, D. A.; Gong, S. Q. Theranostics 2012, 2, 757-768
28. Tang, L.; Deng, L. J. Am. Chem. Soc. 2002, 124, 2870-2871
29. Bourissou, D.; Moebs-Sanchez, S.; Martin-Vaca, B. C. R. Chim. 2007, 10, 775-794
30. Tong, R.; Christian, D. A.; Tang, L.; Cabral, H.; Baker, J. R.; Kataoka, K.; Discher, D. E.; Cheng, J. J. MRS Bull. 2009, 34, 422-431
31. Tong, R.; Cheng, J. J. Chem. Sci. 2012, 3, 2234-2239
32. Ovitt, T. M.; Coates, G. W. J. Am. Chem. Soc. 1999, 121, 4072-4073
33. Tong, R.; Cheng, J. J. Bioconjugate Chem. 2010, 21, 111-121
34. Gref, R.; Minamitake, Y.; Peracchia, M. T.; Trubetskoy, V.; Torchilin, V.; Langer, R. Science 1994, 263, 1600-1603
35. Farokhzad, O. C.; Cheng, J.; Teply, B. A.; Sherifi, I.; Jon, S.; Kantoff, P. W.; Richie, J. P.; Langer, R. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 6315-6320
36. van Nostrum, C. F.; Veldhuis, T. F. J.; Bos, G. W.; Hennink, W. E. Polymer 2004, 45, 6779-6787
37. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. FASEB J. 2005, 19, 311-330
38. Caliceti, P.; Veronese, F. M. Adv. Drug Delivery Rev. 2003, 55, 1261-1277
39. Kjoniksen, A. L.; Joabsson, F.; Thuresson, K.; Nystrom, B. J. Phys. Chem. B 1999, 103, 9818-9825
40. Pierri, E.; Avgoustakis, K. J. Biomed. Mater. Res., Part A 2005, 75A, 639-647
41. Gao, X. H.; Cui, Y. Y.; Levenson, R. M.; Chung, L. W. K.; Nie, S. M. Nat. Biotechnol. 2004, 22, 969-976
42. Heath, J. R.; Davis, M. E. Annu. Rev. Med. 2008, 59, 251-265